| ? | ||||||||||||
|
||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| 購(gòu)買進(jìn)口儀器、試劑和耗材——就在始于2001年的畢特博生物 www.gducity.com |
已證實(shí)內(nèi)毒素水平超低
淋巴細(xì)胞分離液 (LSM) 可用于在體外從稀釋的全血中進(jìn)行淋巴細(xì)胞的分離。其分離原理為密度梯度離心，利用全血中不同細(xì)胞類型比重的差異通過(guò)離心完成細(xì)胞的分離 (圖1)。康寧 cellgro®淋巴分離液是一種無(wú)菌的等滲聚蔗糖和泛影酸鈉溶液，粘度低，在20℃下密度為1.077-1.080g/mL。
除了兩種現(xiàn)成的LSM產(chǎn)品，康寧可以根據(jù)您的需求，提供不同體積和包裝的產(chǎn)品定制。
特點(diǎn)
在FDA注冊(cè)的，經(jīng)ISO13485:2003質(zhì)量認(rèn)證的cGMP車間進(jìn)行生產(chǎn)
依據(jù)SAL 10 的水平無(wú)菌過(guò)濾，高質(zhì)量標(biāo)準(zhǔn)
超低內(nèi)毒素濃度 (＜0.25EU/ml@1:10稀釋）
眾多文獻(xiàn)引用
可定制不同規(guī)格
圖1：全血在LSM中離心后的各類細(xì)胞分布
訂購(gòu)信息
 參考文獻(xiàn)
1. Viral MHC class I inhibition evades CD8+T-cell effector responses in vivo but not CD8+T-cell priming. Maria D. Gainey et. al,PNAS, Nov 2012; 109: E3260 - E3267.
2. Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation. R Muthuswamy et. al., Cancer Res July 15, 200868; 5972
3. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Natasa Obermajer et. al., Blood, Nov 2011; 118: 5498 - 5505.
4. Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Julia K. Tietze et.al, Blood, Mar 2012; 119: 3073 - 3083.
5. HLA-DR+ CD38+ CD4+ T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo. Amie L. Meditzet. al., J.Virol., Oct 2011; 85: 10189 - 10200.
6. A Stimulation-Dependent Alternate Core Promoter Links Lymphotoxin α Expression with TGF-β1 and Fibroblast Growth Factor-7 Signaling in Primary Human T Cells. Brian H. Yokley et. al., J. Immunol., May 2013; 190: 4573 – 4584
北京畢特博生物技術(shù)有限責(zé)任公司
http://www.gducity.com
400熱線：400-833-9299
電話：010-82015225
傳真：010-62015131
聯(lián)系人：張鈺
手機(jī)：13366202681
QQ：1050524889
|
購(gòu)買進(jìn)口儀器、試劑和耗材——就在始于2001年的畢特博生物
www.gducity.com |
|
